Therapeutic drug monitoring of antibiotics--author's reply

Affiliations

¹ Burns, Trauma, and Critical Care Research Centre, University of Queensland, Herston, Brisbane, QLD 4029, Australia; Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; Institute of Translational Medicine, University of Liverpool, Liverpool, UK. Electronic address: j.roberts2@uq.edu.au.

Comment

Jason A Roberts et al. Lancet Infect Dis. 2014 Dec.

. 2014 Dec;14(12):1181.

doi: 10.1016/S1473-3099(14)71007-2. Epub 2014 Nov 17.

¹ Burns, Trauma, and Critical Care Research Centre, University of Queensland, Herston, Brisbane, QLD 4029, Australia; Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; Institute of Translational Medicine, University of Liverpool, Liverpool, UK. Electronic address: j.roberts2@uq.edu.au.

No abstract available

Comment on

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL; International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases. Roberts JA, et al. Lancet Infect Dis. 2014 Jun;14(6):498-509. doi: 10.1016/S1473-3099(14)70036-2. Epub 2014 Apr 24. Lancet Infect Dis. 2014. PMID: 24768475 Free PMC article. Review.
Therapeutic drug monitoring of antibiotics.
Bertino JS Jr. Bertino JS Jr. Lancet Infect Dis. 2014 Dec;14(12):1180-1. doi: 10.1016/S1473-3099(14)70988-0. Epub 2014 Nov 17. Lancet Infect Dis. 2014. PMID: 25455984 No abstract available.